Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 110 entries
Sorted by: Best Match Show Resources per page
Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation.

Pharmaceutics

Abbas N, Oswald IDH, Pulham CR.
PMID: 28509850
Pharmaceutics. 2017 May 16;9(2). doi: 10.3390/pharmaceutics9020016.

High-pressure crystallisation has been successfully used as an alternative technique to prepare Form II of a non-steroidal anti-inflammatory drug, mefenamic acid (MA). A single crystal of Form II, denoted as high-pressure Form II, was grown at 0.3 GPa from...

Cite
Abbas N, Oswald IDH, Pulham CR. Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation. Pharmaceutics. 2017;9(2)doi: 10.3390/pharmaceutics9020016.
Abbas, N., Oswald, I. D. H., & Pulham, C. R. (2017). Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation. Pharmaceutics, 9(2), . https://doi.org/10.3390/pharmaceutics9020016
Abbas, Nasir, et al. "Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation." Pharmaceutics vol. 9,2 (2017). doi: https://doi.org/10.3390/pharmaceutics9020016
Abbas N, Oswald IDH, Pulham CR. Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation. Pharmaceutics. 2017 May 16;9(2). doi: 10.3390/pharmaceutics9020016. PMID: 28509850; PMCID: PMC5489933.
Copy Download .nbib Format: NLM
Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis.

Evidence-based complementary and alternative medicine : eCAM

Chen CX, Barrett B, Kwekkeboom KL.
PMID: 27274753
Evid Based Complement Alternat Med. 2016;2016:6295737. doi: 10.1155/2016/6295737. Epub 2016 May 05.

This systematic review examines the efficacy of oral ginger for dysmenorrhea. Key biomedical databases and grey literature were searched. We included randomized controlled trials comparing oral ginger against placebo or active treatment in women with dysmenorrhea. Six trials were...

Cite
Chen CX, Barrett B, Kwekkeboom KL. Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2016;2016:6295737doi: 10.1155/2016/6295737.
Chen, C. X., Barrett, B., & Kwekkeboom, K. L. (2016). Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis. Evidence-based complementary and alternative medicine : eCAM, 20166295737. https://doi.org/10.1155/2016/6295737
Chen, Chen X, et al. "Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis." Evidence-based complementary and alternative medicine : eCAM vol. 2016 (2016): 6295737. doi: https://doi.org/10.1155/2016/6295737
Chen CX, Barrett B, Kwekkeboom KL. Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2016;2016:6295737. doi: 10.1155/2016/6295737. Epub 2016 May 05. PMID: 27274753; PMCID: PMC4871956.
Copy Download .nbib Format: NLM
Preparation and Determination of Drug-Polymer Interaction and In-vitro Release of Mefenamic Acid Microspheres Made of CelluloseAcetate Phthalate and/or Ethylcellulose Polymers.

Iranian journal of pharmaceutical research : IJPR

Jelvehgari M, Hassanzadeh D, Kiafar F, Delf Loveym B, Amiri S.
PMID: 24250377
Iran J Pharm Res. 2011;10(3):457-67.

The objective of this study was to formulate and evaluate the drug-polymer interaction of mefenamic acid (MA) using two polymers with different characteristics as ethylcellulose (EC) and/or cellulose acetate phthalate (CAP). Microspheres were prepared by the modified emulsion solvent...

Cite
Jelvehgari M, Hassanzadeh D, Kiafar F, et al. Preparation and Determination of Drug-Polymer Interaction and In-vitro Release of Mefenamic Acid Microspheres Made of CelluloseAcetate Phthalate and/or Ethylcellulose Polymers. Iran J Pharm Res. 2011;10(3):457-67
Jelvehgari, M., Hassanzadeh, D., Kiafar, F., Delf Loveym, B., & Amiri, S. (2011). Preparation and Determination of Drug-Polymer Interaction and In-vitro Release of Mefenamic Acid Microspheres Made of CelluloseAcetate Phthalate and/or Ethylcellulose Polymers. Iranian journal of pharmaceutical research : IJPR, 10(3), 457-67.
Jelvehgari, Mitra, et al. "Preparation and Determination of Drug-Polymer Interaction and In-vitro Release of Mefenamic Acid Microspheres Made of CelluloseAcetate Phthalate and/or Ethylcellulose Polymers." Iranian journal of pharmaceutical research : IJPR vol. 10,3 (2011): 457-67.
Jelvehgari M, Hassanzadeh D, Kiafar F, Delf Loveym B, Amiri S. Preparation and Determination of Drug-Polymer Interaction and In-vitro Release of Mefenamic Acid Microspheres Made of CelluloseAcetate Phthalate and/or Ethylcellulose Polymers. Iran J Pharm Res. 2011;10(3):457-67. PMID: 24250377; PMCID: PMC3813045.
Copy Download .nbib Format: NLM
Menstrual loss of renal function: a case of mefenamic acid induced renal cortical necrosis.

Clinical nephrology

Ma TK, Ng JK, Kwan BC, Szeto CC, Li PK.
PMID: 27443568
Clin Nephrol. 2016 Sep;86(9):162-4. doi: 10.5414/CN108848.

No abstract available.

Cite
Ma TK, Ng JK, Kwan BC, et al. Menstrual loss of renal function: a case of mefenamic acid induced renal cortical necrosis. Clin Nephrol. 2016;86(9):162-4doi: 10.5414/CN108848.
Ma, T. K., Ng, J. K., Kwan, B. C., Szeto, C. C., & Li, P. K. (2016). Menstrual loss of renal function: a case of mefenamic acid induced renal cortical necrosis. Clinical nephrology, 86(9), 162-4. https://doi.org/10.5414/CN108848
Ma, Terry King-Wing, et al. "Menstrual loss of renal function: a case of mefenamic acid induced renal cortical necrosis." Clinical nephrology vol. 86,9 (2016): 162-4. doi: https://doi.org/10.5414/CN108848
Ma TK, Ng JK, Kwan BC, Szeto CC, Li PK. Menstrual loss of renal function: a case of mefenamic acid induced renal cortical necrosis. Clin Nephrol. 2016 Sep;86(9):162-4. doi: 10.5414/CN108848. PMID: 27443568.
Copy Download .nbib Format: NLM
Gas Chromatographic and Spectrophotometric Determination of Diclofenac Sodium, Ibuprofen, and Mefenamic Acid in Urine and Blood Samples.

Turkish journal of pharmaceutical sciences

Jalbani NS, Solangi AR, Khuhawar MY, Memon S, Junejo R, Memon AA.
PMID: 33177925
Turk J Pharm Sci. 2020 Oct;17(5):465-473. doi: 10.4274/tjps.galenos.2019.42243. Epub 2020 Oct 30.

OBJECTIVES: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for the treatment of acute to chronic pain. A simple, fast, and reliable gas chromatographic (GC) method with flame ionization detection has been developed for the determination of NSAIDs such as...

Cite
Jalbani NS, Solangi AR, Khuhawar MY, et al. Gas Chromatographic and Spectrophotometric Determination of Diclofenac Sodium, Ibuprofen, and Mefenamic Acid in Urine and Blood Samples. Turk J Pharm Sci. 2020;17(5):465-473doi: 10.4274/tjps.galenos.2019.42243.
Jalbani, N. S., Solangi, A. R., Khuhawar, M. Y., Memon, S., Junejo, R., & Memon, A. A. (2020). Gas Chromatographic and Spectrophotometric Determination of Diclofenac Sodium, Ibuprofen, and Mefenamic Acid in Urine and Blood Samples. Turkish journal of pharmaceutical sciences, 17(5), 465-473. https://doi.org/10.4274/tjps.galenos.2019.42243
Jalbani, Nida S, et al. "Gas Chromatographic and Spectrophotometric Determination of Diclofenac Sodium, Ibuprofen, and Mefenamic Acid in Urine and Blood Samples." Turkish journal of pharmaceutical sciences vol. 17,5 (2020): 465-473. doi: https://doi.org/10.4274/tjps.galenos.2019.42243
Jalbani NS, Solangi AR, Khuhawar MY, Memon S, Junejo R, Memon AA. Gas Chromatographic and Spectrophotometric Determination of Diclofenac Sodium, Ibuprofen, and Mefenamic Acid in Urine and Blood Samples. Turk J Pharm Sci. 2020 Oct;17(5):465-473. doi: 10.4274/tjps.galenos.2019.42243. Epub 2020 Oct 30. PMID: 33177925; PMCID: PMC7650736.
Copy Download .nbib Format: NLM
Comparison of Misoprostol and Mefenamic Acid on Reducing Menstrual Bleeding in Patients Suffering From Heavy Menstrual Bleeding.

Journal of family & reproductive health

Eftekhar T, Ghaemi M, Abedi A, Shirazi M.
PMID: 32201488
J Family Reprod Health. 2019 Sep;13(3):141-145.

No abstract available.

Cite
Eftekhar T, Ghaemi M, Abedi A, et al. Comparison of Misoprostol and Mefenamic Acid on Reducing Menstrual Bleeding in Patients Suffering From Heavy Menstrual Bleeding. J Family Reprod Health. 2019;13(3):141-145
Eftekhar, T., Ghaemi, M., Abedi, A., & Shirazi, M. (2019). Comparison of Misoprostol and Mefenamic Acid on Reducing Menstrual Bleeding in Patients Suffering From Heavy Menstrual Bleeding. Journal of family & reproductive health, 13(3), 141-145.
Eftekhar, Tahereh, et al. "Comparison of Misoprostol and Mefenamic Acid on Reducing Menstrual Bleeding in Patients Suffering From Heavy Menstrual Bleeding." Journal of family & reproductive health vol. 13,3 (2019): 141-145.
Eftekhar T, Ghaemi M, Abedi A, Shirazi M. Comparison of Misoprostol and Mefenamic Acid on Reducing Menstrual Bleeding in Patients Suffering From Heavy Menstrual Bleeding. J Family Reprod Health. 2019 Sep;13(3):141-145. PMID: 32201488; PMCID: PMC7072028.
Copy Download .nbib Format: NLM
Bacterial versus fungal laccase: potential for micropollutant degradation.

AMB Express

Margot J, Bennati-Granier C, Maillard J, Blánquez P, Barry DA, Holliger C.
PMID: 24152339
AMB Express. 2013 Oct 24;3(1):63. doi: 10.1186/2191-0855-3-63.

Relatively high concentrations of micropollutants in municipal wastewater treatment plant (WWTP) effluents underscore the necessity to develop additional treatment steps prior to discharge of treated wastewater. Microorganisms that produce unspecific oxidative enzymes such as laccases are a potential means...

Cite
Margot J, Bennati-Granier C, Maillard J, et al. Bacterial versus fungal laccase: potential for micropollutant degradation. AMB Express. 2013;3(1):63doi: 10.1186/2191-0855-3-63.
Margot, J., Bennati-Granier, C., Maillard, J., Blánquez, P., Barry, D. A., & Holliger, C. (2013). Bacterial versus fungal laccase: potential for micropollutant degradation. AMB Express, 3(1), 63. https://doi.org/10.1186/2191-0855-3-63
Margot, Jonas, et al. "Bacterial versus fungal laccase: potential for micropollutant degradation." AMB Express vol. 3,1 (2013): 63. doi: https://doi.org/10.1186/2191-0855-3-63
Margot J, Bennati-Granier C, Maillard J, Blánquez P, Barry DA, Holliger C. Bacterial versus fungal laccase: potential for micropollutant degradation. AMB Express. 2013 Oct 24;3(1):63. doi: 10.1186/2191-0855-3-63. PMID: 24152339; PMCID: PMC3819643.
Copy Download .nbib Format: NLM
SUBACUTE THYROIDITIS IN A PATIENT WITH CORONAVIRUS DISEASE 2019.

AACE clinical case reports

San Juan MDJ, Florencio MQV, Joven MH.
PMID: 33244504
AACE Clin Case Rep. 2020 Nov 23;6(6):e361-e364. doi: 10.4158/ACCR-2020-0524. eCollection 2020.

OBJECTIVE: Subacute thyroiditis (SAT) is an inflammatory disorder of the thyroid gland that causes destructive thyrotoxicosis and is attributed to a viral or post-viral response. SARS-CoV-2 is a novel coronavirus that caused a global pandemic in 2020. We present...

Cite
San Juan MDJ, Florencio MQV, Joven MH. SUBACUTE THYROIDITIS IN A PATIENT WITH CORONAVIRUS DISEASE 2019. AACE Clin Case Rep. 2020;6(6):e361-e364doi: 10.4158/ACCR-2020-0524.
San Juan, M. D. J., Florencio, M. Q. V., & Joven, M. H. (2020). SUBACUTE THYROIDITIS IN A PATIENT WITH CORONAVIRUS DISEASE 2019. AACE clinical case reports, 6(6), e361-e364. https://doi.org/10.4158/ACCR-2020-0524
San Juan, Mari Des J, et al. "SUBACUTE THYROIDITIS IN A PATIENT WITH CORONAVIRUS DISEASE 2019." AACE clinical case reports vol. 6,6 (2020): e361-e364. doi: https://doi.org/10.4158/ACCR-2020-0524
San Juan MDJ, Florencio MQV, Joven MH. SUBACUTE THYROIDITIS IN A PATIENT WITH CORONAVIRUS DISEASE 2019. AACE Clin Case Rep. 2020 Nov 23;6(6):e361-e364. doi: 10.4158/ACCR-2020-0524. eCollection 2020. PMID: 33244504; PMCID: PMC7685420.
Copy Download .nbib Format: NLM
Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial.

International journal of molecular medicine

Guzman-Esquivel J, Galvan-Salazar HR, Guzman-Solorzano HP, Cuevas-Velazquez AC, Guzman-Solorzano JA, Mokay-Ramirez KA, Paz-Michel BA, Murillo-Zamora E, Delgado-Enciso J, Melnikov V, Delgado-Enciso OG, Rodriguez-Sanchez IP, Martinez-Fierro ML, Rojas-Larios F, Walle-Guillen M, Cardenas-Aguilar CB, Beas-Guzman O, Chaviano-Conesa D, Garcia-Garcia HS, Delgado-Enciso I.
PMID: 35029292
Int J Mol Med. 2022 Mar;49(3). doi: 10.3892/ijmm.2022.5084. Epub 2022 Jan 14.

Mefenamic acid is a non‑steroidal anti‑inflammatory drug exhibiting a wide range of anti‑inflammatory, antipyretic, analgesic and probable antiviral activities. The present study evaluated the efficacy of treatment with mefenamic acid combined with standard medical care vs. standard medical care...

Cite
Guzman-Esquivel J, Galvan-Salazar HR, Guzman-Solorzano HP, et al. Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial. Int J Mol Med. 2022;49(3)doi: 10.3892/ijmm.2022.5084.
Guzman-Esquivel, J., Galvan-Salazar, H. R., Guzman-Solorzano, H. P., Cuevas-Velazquez, A. C., Guzman-Solorzano, J. A., Mokay-Ramirez, K. A., Paz-Michel, B. A., Murillo-Zamora, E., Delgado-Enciso, J., Melnikov, V., Delgado-Enciso, O. G., Rodriguez-Sanchez, I. P., Martinez-Fierro, M. L., Rojas-Larios, F., Walle-Guillen, M., Cardenas-Aguilar, C. B., Beas-Guzman, O., Chaviano-Conesa, D., Garcia-Garcia, H. S., & Delgado-Enciso, I. (2022). Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial. International journal of molecular medicine, 49(3), . https://doi.org/10.3892/ijmm.2022.5084
Guzman-Esquivel, Jose, et al. "Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial." International journal of molecular medicine vol. 49,3 (2022). doi: https://doi.org/10.3892/ijmm.2022.5084
Guzman-Esquivel J, Galvan-Salazar HR, Guzman-Solorzano HP, Cuevas-Velazquez AC, Guzman-Solorzano JA, Mokay-Ramirez KA, Paz-Michel BA, Murillo-Zamora E, Delgado-Enciso J, Melnikov V, Delgado-Enciso OG, Rodriguez-Sanchez IP, Martinez-Fierro ML, Rojas-Larios F, Walle-Guillen M, Cardenas-Aguilar CB, Beas-Guzman O, Chaviano-Conesa D, Garcia-Garcia HS, Delgado-Enciso I. Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial. Int J Mol Med. 2022 Mar;49(3). doi: 10.3892/ijmm.2022.5084. Epub 2022 Jan 14. PMID: 35029292.
Copy Download .nbib Format: NLM
Evaluation of mint efficacy regarding dysmenorrhea in comparison with mefenamic acid: A double blinded randomized crossover study.

Iranian journal of nursing and midwifery research

Masoumi SZ, Asl HR, Poorolajal J, Panah MH, Oliaei SR.
PMID: 27563318
Iran J Nurs Midwifery Res. 2016 Jul-Aug;21(4):363-7. doi: 10.4103/1735-9066.185574.

BACKGROUND: Menthol is the most important active material in mint and different mechanisms have been suggested for the way mint functions, most of which emphasize its analgesic effect owing to the presence of a group of temporary protein receptors....

Cite
Masoumi SZ, Asl HR, Poorolajal J, et al. Evaluation of mint efficacy regarding dysmenorrhea in comparison with mefenamic acid: A double blinded randomized crossover study. Iran J Nurs Midwifery Res. 2016;21(4):363-7doi: 10.4103/1735-9066.185574.
Masoumi, S. Z., Asl, H. R., Poorolajal, J., Panah, M. H., & Oliaei, S. R. (2016). Evaluation of mint efficacy regarding dysmenorrhea in comparison with mefenamic acid: A double blinded randomized crossover study. Iranian journal of nursing and midwifery research, 21(4), 363-7. https://doi.org/10.4103/1735-9066.185574
Masoumi, Seyedeh Zahra, et al. "Evaluation of mint efficacy regarding dysmenorrhea in comparison with mefenamic acid: A double blinded randomized crossover study." Iranian journal of nursing and midwifery research vol. 21,4 (2016): 363-7. doi: https://doi.org/10.4103/1735-9066.185574
Masoumi SZ, Asl HR, Poorolajal J, Panah MH, Oliaei SR. Evaluation of mint efficacy regarding dysmenorrhea in comparison with mefenamic acid: A double blinded randomized crossover study. Iran J Nurs Midwifery Res. 2016 Jul-Aug;21(4):363-7. doi: 10.4103/1735-9066.185574. PMID: 27563318; PMCID: PMC4979258.
Copy Download .nbib Format: NLM
Model-Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes.

CPT: pharmacometrics & systems pharmacology

Jo H, Pilla Reddy V, Parkinson J, Boulton DW, Tang W.
PMID: 33439535
CPT Pharmacometrics Syst Pharmacol. 2021 Feb;10(2):108-118. doi: 10.1002/psp4.12577. Epub 2021 Jan 13.

This analysis reports a quantitative modeling and simulation approach for oral dapagliflozin, a primarily uridine diphosphate-glucuronosyltransferase (UGT)-metabolized human sodium-glucose cotransporter 2 selective inhibitor. A mechanistic dapagliflozin physiologically based pharmacokinetic (PBPK) model was developed using in vitro metabolism and clinical...

Cite
Jo H, Pilla Reddy V, Parkinson J, et al. Model-Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes. CPT Pharmacometrics Syst Pharmacol. 2021;10(2):108-118doi: 10.1002/psp4.12577.
Jo, H., Pilla Reddy, V., Parkinson, J., Boulton, D. W., & Tang, W. (2021). Model-Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes. CPT: pharmacometrics & systems pharmacology, 10(2), 108-118. https://doi.org/10.1002/psp4.12577
Jo, Heeseung, et al. "Model-Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes." CPT: pharmacometrics & systems pharmacology vol. 10,2 (2021): 108-118. doi: https://doi.org/10.1002/psp4.12577
Jo H, Pilla Reddy V, Parkinson J, Boulton DW, Tang W. Model-Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes. CPT Pharmacometrics Syst Pharmacol. 2021 Feb;10(2):108-118. doi: 10.1002/psp4.12577. Epub 2021 Jan 13. PMID: 33439535; PMCID: PMC7894404.
Copy Download .nbib Format: NLM
Solvates of selected fenamic acids with substituted pyridines: structure, thermal stability and desolvation.

Acta crystallographica Section B, Structural science, crystal engineering and materials

Bouanga Boudiombo JS, Jacobs A.
PMID: 27910834
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Dec 01;72:836-845. doi: 10.1107/S2052520616014128. Epub 2016 Nov 05.

Mefenamic acid (MA) formed solvates with 2-picoline (2PIC), 3-picoline (3PIC), 4-picoline (4PIC) and 3-chloropyridine (3CLPYR). The solvates crystallized in the space group P\bar 1 with the carboxylic acid of MA hydrogen-bonded to the nitrogen of the substituted pyridine. Tolfenamic...

Cite
Bouanga Boudiombo JS, Jacobs A. Solvates of selected fenamic acids with substituted pyridines: structure, thermal stability and desolvation. Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016;72:836-845doi: 10.1107/S2052520616014128.
Bouanga Boudiombo, J. S., & Jacobs, A. (2016). Solvates of selected fenamic acids with substituted pyridines: structure, thermal stability and desolvation. Acta crystallographica Section B, Structural science, crystal engineering and materials, 72836-845. https://doi.org/10.1107/S2052520616014128
Bouanga Boudiombo, Jacky S, and Jacobs, Ayesha. "Solvates of selected fenamic acids with substituted pyridines: structure, thermal stability and desolvation." Acta crystallographica Section B, Structural science, crystal engineering and materials vol. 72 (2016): 836-845. doi: https://doi.org/10.1107/S2052520616014128
Bouanga Boudiombo JS, Jacobs A. Solvates of selected fenamic acids with substituted pyridines: structure, thermal stability and desolvation. Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Dec 01;72:836-845. doi: 10.1107/S2052520616014128. Epub 2016 Nov 05. PMID: 27910834.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 110 entries